Immediate Impact
55 standout
Citing Papers
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
2022 Standout
RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies
2022 Standout
Works of Robert Williams being referenced
Cost Effectiveness of Ezetimibe in Patients with Cardiovascular Disease and Statin Intolerance or Contraindications
2008
Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation
2008
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Robert Williams | 209 | 158 | 197 | 18 | 433 | |
| Lisa B. Feng | 83 | 219 | 187 | 8 | 477 | |
| Cody Horst | 152 | 167 | 73 | 9 | 490 | |
| Carolyn DeCoster | 154 | 202 | 55 | 25 | 417 | |
| Stephanie Woolhandler | 103 | 161 | 133 | 13 | 383 | |
| Pascal Vignally | 113 | 161 | 225 | 19 | 478 | |
| Richard P. Kusserow | 142 | 150 | 62 | 9 | 470 | |
| Amber K. Sabbatini | 157 | 179 | 287 | 34 | 495 | |
| Christopher Richter | 173 | 185 | 313 | 12 | 423 | |
| Carlos Irwin A. Oronce | 131 | 260 | 70 | 21 | 412 | |
| Louella Vaughan | 116 | 156 | 255 | 21 | 511 |
All Works
Loading papers...